M
M. A. Nauck
Publications - 2
Citations - 485
M. A. Nauck is an academic researcher. The author has contributed to research in topics: Type 2 diabetes & Sulfonylurea. The author has an hindex of 2, co-authored 2 publications receiving 479 citations.
Papers
More filters
Journal ArticleDOI
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.
M. A. Nauck,S. Duran,Dennis Kim,Don Johns,Justin Northrup,Andreas Festa,R. Brodows,Michael E. Trautmann +7 more
TL;DR: Exenatide treatment resulted in HbA1c reduction similar to biphasic insulin aspart and provided better postprandial glycaemic control, making it a potential alternative for the treatment of type 2 diabetes.
Journal ArticleDOI
Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267
TL;DR: In this article, the authors present a non-inferiority study of the treat-to-target trials of insulin mixtures and show that patients with biphasic insulin achieved a mean HbA1c of 8.15% at endpoint.